Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Oct 15, 2024; 16(10): 4080-4091
Published online Oct 15, 2024. doi: 10.4251/wjgo.v16.i10.4080
Published online Oct 15, 2024. doi: 10.4251/wjgo.v16.i10.4080
Characteristic | Autoimmune atrophic gastritis | H. pylori-associated atrophic gastritis |
Etiology | Autoimmune destruction of parietal cells[4,5] | Chronic infection by H. pylori[8,10] |
Gastric acid secretion | Reduced, leading to hypo/achlorhydria[3] | Initially increased, but later reduced as atrophy progresses[9] |
Location of atrophy | Body and fundus of the stomach[4,5] | Antrum and body of the stomach[12,43] |
Serum markers | High gastrin, low pepsinogen I/II ratio, presence of antibodies against parietal cells[4,5] | Positive anti-H. pylori antibodies, variable pepsinogen I/II ratio[43,44] |
Gastric microbiota | Altered, with decreased diversity[13,14] | Altered, often with increased colonization by non-H. pylori species[13,15] |
Risk of gastric cancer | Increased risk, particularly for neuroendocrine tumors[36,39] | Increased risk of adenocarcinoma, particularly intestinal type[10,12] |
Associated conditions | Pernicious anemia, other autoimmune diseases like thyroiditis[4,33] | Gastric ulcer, duodenal ulcer, and MALT lymphoma[6,10] |
- Citation: Ma XZ, Zhou N, Luo X, Guo SQ, Mai P. Update understanding on diagnosis and histopathological examination of atrophic gastritis: A review. World J Gastrointest Oncol 2024; 16(10): 4080-4091
- URL: https://www.wjgnet.com/1948-5204/full/v16/i10/4080.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i10.4080